VX16-809-120: A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety ofOrkambi in US Patients Who Completed Study VX12-809-105 Part A

Project: Research project

Project Details

Description

VX16-809-120: A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients Who Completed Study VX12-809-105 Part A
StatusFinished
Effective start/end date4/1/1812/31/19

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.